A Look Back at the Rapidly Evolving Treatment Landscape for Early-Stage NSCLC

Mark Socinski, MD

Disclosures

January 30, 2023

Mark Socinski, MD, describes the rise of a new dedication toward the diagnosis and treatment of early-stage non–small cell lung cancer.

Recalling an era early in his career, Dr Socinski details the prevalent mode of surgical practice before proper preoperative and intraoperative staging of the mediastinal lymph nodes was standard practice.

The intervening years have seen a new approach marked by the development of a surgical subspecialty more attuned to the needs of patients with lung cancer and a heightened regard for testing of mediastinal lymph nodes, permitting more accurate staging of disease and concomitant therapeutic efficacy.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....